Trusted Resources: Community Center
A Guide to Understanding MPS III
MPS III is a mucopolysaccharide disease also known as Sanfilippo syndrome. It takes its name from Dr. Sylvester Sanfilippo, one of the U.S. doctors who described the condition in 1963.
What causes the disease?
• Mucopolysaccharides are chains of sugar molecules used to build connective tissues in the body.
• “muco” refers to the thick jelly-like consistency of the molecules
• “poly” means many
• “saccharide” is a general term for a sugar molecule
The body constantly replaces used materials and breaks them down for disposal. MPS III patients are missing an enzyme essential to breaking down the mucopolysaccharide heparan sulphate. These materials remain stored in the body’s cells, causing progressive damage. Babies may show little sign of the disease, but as cells sustain damage, symptoms start to appear.
BookmarkRelated Content
-
Cure Sanfilippo Foundation – InstagramCure Sanfilippo Foundation is a non prof...
-
Developing a Treatment Plan for Sanfilippo SyndromeSanfilippo syndrome is a neurodegenerati...
-
Europe Grants Orphan Drug Status to JR-441, ERT for Sanfilippo AThe European Commission has granted an o...
-
MPS IIIA (Sanfilippo Syndrome, Type A) in a 7-Year-Old Girlhttps://slideplayer.com/slide/13595382/...
-
Iminosugar C-Glycosides Work as Pharmacological Chaperones of NAGLU, a Glycosidase Involved in MPS IIIB Rare DiseaseMucopolysaccharidosis type IIIB is a dev...
-
Gene Therapy for Sanfilippo: Where We Are NowGene therapy is a promising approach for...
-
Impaired Neural Differentiation of MPS IIIA Patient Induced Pluripotent Stem Cell-Derived Neural Progenitor CellsMucopolysaccharidosis type IIIA (MPS III...
